Cargando…

Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19—A Swedish Cohort Study

Dexamethasone (Dex) has been shown to decrease mortality in severe coronavirus disease 2019 (COVID-19), but the mechanism is not fully elucidated. We aimed to investigate the physiological and immunological effects associated with Dex administration in patients admitted to intensive care with severe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asif, Sana, Frithiof, Robert, Larsson, Anders, Franzén, Stephanie, Anderberg, Sara Bülow, Kristensen, Bjarne, Hultström, Michael, Lipcsey, Miklos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855905/ https://www.ncbi.nlm.nih.gov/pubmed/36672672 http://dx.doi.org/10.3390/biomedicines11010164

Ejemplares similares

Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care
por: Asif, Sana, et al.
Publicado: (2020)

COVID‐19 patients in intensive care develop predominantly oliguric acute kidney injury
por: Luther, Tomas, et al.
Publicado: (2020)

Plasma endostatin correlates with hypoxia and mortality in COVID-19-associated acute respiratory failure
por: Asif, Sana, et al.
Publicado: (2021)

Systemic Human Neutrophil Lipocalin Associates with Severe Acute Kidney Injury in SARS-CoV-2 Pneumonia
por: Bülow Anderberg, Sara, et al.
Publicado: (2021)

Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients
por: Bülow Anderberg, Sara, et al.
Publicado: (2021)

The swedish covid‐19 intensive care cohort: Risk factors of ICU admission and ICU mortality
por: Ahlström, Björn, et al.
Publicado: (2021)

The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients
por: Järhult, Josef D., et al.
Publicado: (2021)

Shrunken Pore Syndrome Is Frequently Occurring in Severe COVID-19
por: Larsson, Anders O., et al.
Publicado: (2022)

Severe acute kidney injury associated with progression of chronic kidney disease after critical COVID-19
por: Hultström, Michael, et al.
Publicado: (2021)

Plasma Leptin Is Increased in Intensive Care Patients with COVID-19—An Investigation Performed in the PronMed-Cohort
por: Larsson, Anders, et al.
Publicado: (2021)

Blood type A associates with critical COVID-19 and death in a Swedish cohort
por: Hultström, Michael, et al.
Publicado: (2020)

Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients
por: Gradin, A., et al.
Publicado: (2021)

Prior physical illness predicts death better than acute physiological derangement on intensive care unit admission in COVID-19: A Swedish registry study
por: Stattin, Karl, et al.
Publicado: (2023)

High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19
por: Karawajczyk, Malgorzata, et al.
Publicado: (2021)

Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study
por: Sancho Ferrando, Elena, et al.
Publicado: (2022)

Differential Bias for Creatinine- and Cystatin C- Derived Estimated Glomerular Filtration Rate in Critical COVID-19
por: Larsson, Anders O., et al.
Publicado: (2022)

Estimated glomerular filtration rates are higher when creatinine‐based equations are compared with a cystatin C‐based equation in coronavirus disease 2019
por: Larsson, Anders O., et al.
Publicado: (2022)

Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients
por: Frithiof, Robert, et al.
Publicado: (2020)

Infectious SARS-CoV-2 is rarely present in the nasopharynx samples collected from Swedish hospitalized critically ill COVID-19 patients
por: Ling, Jiaxin, et al.
Publicado: (2022)

Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients
por: Stattin, K., et al.
Publicado: (2020)

Intensive care‐treated COVID‐19 patients’ perception of their illness and remaining symptoms
por: Wallin, Ewa, et al.
Publicado: (2021)

Poor long-term recovery after critical COVID-19 during 12 months longitudinal follow-up()
por: Larsson, Ing-Marie, et al.
Publicado: (2023)

A comparison of impact of comorbidities and demographics on 60-day mortality in ICU patients with COVID-19, sepsis and acute respiratory distress syndrome
por: Ahlström, Björn, et al.
Publicado: (2022)

Chest dual-energy CT to assess the effects of steroids on lung function in severe COVID-19 patients
por: Perchiazzi, Gaetano, et al.
Publicado: (2022)

Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients
por: Lagedal, Rickard, et al.
Publicado: (2022)

The Evolution of Blood Cell Phenotypes, Intracellular and Plasma Cytokines and Morphological Changes in Critically Ill COVID-19 Patients
por: Berghäll, Elisabeth, et al.
Publicado: (2022)

Correction: Berghäll et al. The Evolution of Blood Cell Phenotypes, Intracellular and Plasma Cytokines and Morphological Changes in Critically Ill COVID-19 Patients. Biomedicines 2022, 10, 934
por: Berghäll, Elisabeth, et al.
Publicado: (2023)

Antibiotic use during coronavirus disease 2019 intensive care unit shape multidrug resistance bacteriuria: A Swedish longitudinal prospective study
por: Karlsson, Philip A., et al.
Publicado: (2023)

Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study
por: Galien, Sarah, et al.
Publicado: (2021)

Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation—A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients
por: Hultström, Michael, et al.
Publicado: (2022)

In an endotoxaemic model, antibiotic clearance can be affected by different central venous catheter positions, during renal replacement therapy
por: Bandert, Anna, et al.
Publicado: (2023)

Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients
por: Huckriede, Joram, et al.
Publicado: (2021)

Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19
por: Bark, Lovisa, et al.
Publicado: (2023)

ECG pathology and its association with death in critically ill COVID-19 patients, a cohort study
por: Rosén, Jacob, et al.
Publicado: (2021)

Decreased renal perfusion during acute kidney injury in critical COVID-19 assessed by magnetic resonance imaging: a prospective case control study
por: Luther, Tomas, et al.
Publicado: (2022)

Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients
por: Hultström, Michael, et al.
Publicado: (2022)

Histone H3 Cleavage in Severe COVID-19 ICU Patients
por: Huckriede, Joram, et al.
Publicado: (2021)

Immuno-Modulatory Effects of Intervertebral Disc Cells
por: Bermudez-Lekerika, Paola, et al.
Publicado: (2022)

Analysis of Calprotectin as an Early Marker of Infections Is Economically Advantageous in Intensive Care-Treated Patients
por: Havelka, Aleksandra, et al.
Publicado: (2023)

A quantitative analysis of extension and distribution of lung injury in COVID-19: a prospective study based on chest computed tomography
por: Pellegrini, Mariangela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_47rbtt5leavnbutgdmvmb6sr5c